| Increased proliferation and analysis of differential gene expression in human Wharton's jelly-derived mesenchymal stromal cells under hypoxia U Nekanti, S Dastidar, P Venugopal, S Totey, M Ta International journal of biological sciences 6 (5), 499, 2010 | 228 | 2010 |
| Optimization and scale-up of Wharton's jelly-derived mesenchymal stem cells for clinical applications U Nekanti, L Mohanty, P Venugopal, S Balasubramanian, S Totey, M Ta Stem cell research 5 (3), 244-254, 2010 | 167 | 2010 |
| Are serum-free and xeno-free culture conditions ideal for large scale clinical grade expansion of Wharton’s jelly derived mesenchymal stem cells? A comparative study P Swamynathan, P Venugopal, S Kannan, C Thej, U Kolkundar, ... Stem cell research & therapy 5 (4), 1, 2014 | 129 | 2014 |
| Higher propensity of Wharton's jelly derived mesenchymal stromal cells towards neuronal lineage in comparison to those derived from adipose and bone marrow S Balasubramanian, C Thej, P Venugopal, N Priya, Z Zakaria, ... Cell biology international 37 (5), 507-515, 2013 | 80 | 2013 |
| Isolation, characterization, and gene expression analysis of Wharton’s jelly-derived mesenchymal stem cells under xeno-free culture conditions P Venugopal, S Balasubramanian, AS Majumdar, M Ta Stem cells cloning 4 (1), 39-50, 2011 | 65 | 2011 |
| Comparison of chemokine and receptor gene expression between Wharton's jelly and bone marrow-derived mesenchymal stromal cells S Balasubramanian, P Venugopal, S Sundarraj, Z Zakaria, AS Majumdar, ... Cytotherapy 14 (1), 26-33, 2012 | 64 | 2012 |
| Differential effects on gene transcription and hematopoietic differentiation correlate with GATA2 mutant disease phenotypes. CE Chong, P Venugopal, PH Stokes, YK Lee, PJ Brautigan, DTO Yeung, ... Leukemia, 2017 | 55 | 2017 |
| Splice factor mutations and alternative splicing as drivers of hematopoietic malignancy CN Hahn, P Venugopal, HS Scott, DK Hiwase Immunological reviews 263 (1), 257-278, 2015 | 53 | 2015 |
| Revealing Missing Human Protein Isoforms Based on Ab Initio Prediction, RNA-seq and Proteomics Z Hu, HS Scott, G Qin, G Zheng, X Chu, L Xie, DL Adelson, BE Oftedal, ... Scientific reports 5, 2015 | 52 | 2015 |
| Self-reverting mutations partially correct the blood phenotype in a Diamond Blackfan anemia patient P Venugopal, S Moore, DM Lawrence, AJ George, RD Hannan, SCE Bray, ... haematologica, haematol. 2017.166678, 2017 | 29 | 2017 |
| Characterisation of a compound in-cis GATA2 germline mutation in a pedigree presenting with myelodysplastic syndrome/acute myeloid leukemia with concurrent thrombocytopenia. CN Hahn, PJ Brautigan, CE Chong, A Janssan, P Venugopal, Y Lee, ... Leukemia 29 (8), 1795, 2015 | 16 | 2015 |
| Two monogenic disorders masquerading as one: severe congenital neutropenia with monocytosis and non-syndromic sensorineural hearing loss P Venugopal, L Gagliardi, C Forsyth, J Feng, K Phillips, M Babic, ... BMC Medical Genetics 21 (1), 1-5, 2020 | 3 | 2020 |
| Clinical implications of transient myeloproliferative disorder in a neonate without Down syndrome features V Carruthers, M Nicola, P Venugopal, CN Hahn, HS Scott, T Revesz Journal of paediatrics and child health 53 (10), 1018-1020, 2017 | 3 | 2017 |
| An Integrative Genomic Approach to Examine Mutations and Biological Pathways Associated with Hematological Malignancy Development in DDX41 Mutated Families P Venugopal, JJC Cheah, L Eshraghi, NH Shahrin, C Homan, J Feng, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | 2 | 2019 |
| Australian Familial Haematological Cancer Study-Findings from 15 Years of Aggregated Clinical, Genomic and Transcriptomic Data CN Hahn, M Babic, PJ Brautigan, P Venugopal, K Phillips, J Dobbins, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | 2 | 2019 |
| Familial Clustering of Hematological Malignancies: Harbingers of Wider Germline Cancer Susceptibility AL Brown, M Babic, A Schreiber, J Feng, J Dobbins, P Arts, P Wang, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | 1 | 2019 |
| IMPLICATIONS OF REVERTANT SOMATIC MOSAICISM IN BONE MARROW FAILURE SYNDROMES P Venugopal, M Babic, C Barnett, S Bray, A Brown, J Cheah, R D'Andrea, ... Experimental Hematology 76, S90, 2019 | 1 | 2019 |
| Identification and characterisation of genetic lesions that predispose to and gene expression patterns that contribute to Myeloid malignancies P Venugopal | | 2016 |
Hamish S ScottCenter of Cancer BiologyVerified email at sa.gov.au
